This JAMA Insights Clinical Update reviews bone turnover markers measurable in blood and urine and summarizes evidence supporting their use to predict osteoporosis and osteoporotic fractures, assess treatment adherence and efficacy, and monitor bone loss after drug discontinuation.
No takes yet. Share an insight, caveat, or question.
Douglas C. Bauer (2019) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: